Ascertain the Optimal Starting Dose of Mircera Given Subcutaneously for Maintenance Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease on Dialysis or Not Yet on Dialysis.
Clinical trial NCT03552393 · COMPLETED
Trial details
- NCT number
- NCT03552393
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-03
- Primary completion
- 2021-07-19
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.